Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year
- 1 August 2005
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 187 (2), 131-136
- https://doi.org/10.1192/bjp.187.2.131
Abstract
Background The extent to which antipsychotics improve patients' well-being is uncertain.Keywords
This publication has 21 references indexed in Scilit:
- Pharmacokinetics and tolerability of long-acting risperidone in schizophreniaSchizophrenia Research, 2004
- Treatment of Schizophrenia With Long-Acting Injectable RisperidoneThe Journal of Clinical Psychiatry, 2003
- Relapse Prevention in Schizophrenia With New-Generation Antipsychotics: A Systematic Review and Exploratory Meta-Analysis of Randomized, Controlled TrialsAmerican Journal of Psychiatry, 2003
- Neurocognitive deficits and quality of life in outpatients with schizophreniaProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2002
- PrefaceCurrent Opinion in Psychiatry, 2002
- A Comparison of Risperidone and Haloperidol for the Prevention of Relapse in Patients with SchizophreniaNew England Journal of Medicine, 2002
- S13.03 The usefulness and use of second generation antipsychotic medicationsEuropean Psychiatry, 2000
- The MOS 36-Item Short Form Health SurveyMedical Care, 1998
- The Effects of Risperidone on the Five Dimensions of Schizophrenia Derived by Factor AnalysisThe Journal of Clinical Psychiatry, 1997
- The Positive and Negative Syndrome Scale (PANSS) for SchizophreniaSchizophrenia Bulletin, 1987